When Ken Douglas (PhDPhys'83) learned that optogenetics had become the focus of the 2026 Nobel Prize in Physiology or Medicine, his new book on the subject was already nearing publication. The award, shared by three scientists, recognizes a technique that uses precise light and genetics to control the activity of neurons.
How Optogenetics Works
Optogenetics lets researchers switch specific neurons on or off with light. Because the method acts on defined cells and pathways in living tissue, it can test whether a particular circuit causes a behavior rather than merely correlating with it. Douglas describes the shift as moving neuroscience from observing associations to identifying causal relationships in brain function.
Experiments That Shaped the Field
Douglas points to work by Sheena Josselyn and Paul W. Frankland at the University of Toronto, in which researchers replaced a real odor and foot shock with optogenetic stimulation of the neurons that encoded them. Mice then responded to an odor they had never encountered by avoiding a shock they had never received. Douglas also highlights empathy-circuit studies led by Robert C. Malenka of Stanford, in which observer mice showed heightened responses to another animal's pain.
Why the Book Targets General Readers
Douglas wrote the book for readers curious about science who lack a scientific background. He says his interest grew partly from witnessing serious mental health conditions such as clinical depression, and from the hope that circuit-level research could eventually inform treatments. Those applications remain largely experimental, and much of the evidence comes from animal models.